Uploaded April 2026 | Updated September 2026, 3 days ago
Eli Lilly — the company behind Mounjaro — is pushing the UK to raise NHS drug prices and scrap rebate deals in exchange for investing billions back into the country.
This comes after Mounjaro prices already surged by up to 170% in the UK last year… 👀
Now the big question:
👉 Will this make weight loss treatments like Mounjaro harder to access?
👉 Or is this the cost of innovation?
This could change EVERYTHING for UK patients 🇬🇧💉
#Mounjaro #EliLilly #WeightLoss #NHS #glp1
Eli Lilly — the company behind Mounjaro — is pushing the UK to raise NHS drug prices and scrap rebate deals in exchange for investing billions back into the country.
This comes after Mounjaro prices already surged by up to 170% in the UK last year… 👀
Now the big question:
👉 Will this make weight loss treatments like Mounjaro harder to access?
👉 Or is this the cost of innovation?
This could change EVERYTHING for UK patients 🇬🇧💉
#Mounjaro #EliLilly #WeightLoss #NHS #glp1










